Gastroenterology.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 2429597)

Published in Postgrad Med J on June 01, 1990

Authors

L J O'Donnell1, E M Alstead, M J Farthing

Author Affiliations

1: Department of Gastroenterology, St Bartholomew's Hospital, West Smithfield, London, UK.

Articles citing this

Clinical immunology. Postgrad Med J (1991) 0.75

Articles cited by this

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79

Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet (1989) 9.76

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med (1989) 8.10

Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43

Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut (1962) 6.16

Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78

Malignancy in coeliac disease--effect of a gluten free diet. Gut (1989) 5.58

Shock-wave lithotripsy of gallbladder stones. The first 175 patients. N Engl J Med (1988) 5.53

Successful small-bowel/liver transplantation. Lancet (1990) 4.85

Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet (1989) 4.72

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med (1989) 4.69

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med (1989) 3.45

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med (1989) 2.71

Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut (1989) 2.71

Food-based oral rehydration salt solution for acute childhood diarrhoea. Lancet (1989) 2.56

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46

A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology (1989) 2.40

Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology (1989) 2.37

Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29

Toxicological studies on omeprazole. Scand J Gastroenterol Suppl (1985) 2.19

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol (1988) 2.17

Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA (1989) 2.10

Detection and surveillance of colorectal cancer. JAMA (1989) 2.07

Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06

Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut (1989) 2.06

Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94

Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg (1988) 1.91

Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet (1990) 1.85

Outcome of colectomy for severe idiopathic constipation. Gut (1988) 1.82

Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology (1989) 1.81

Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter. N Engl J Med (1989) 1.78

24-hour recording of esophageal pressure and pH in patients with noncardiac chest pain. Gastroenterology (1986) 1.75

Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust (1989) 1.73

Hepatitis C: and miles to go before we sleep. N Engl J Med (1989) 1.67

A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Ed) (1985) 1.62

Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut (1989) 1.61

Intestinal electrolyte transport and diarrheal disease (1). N Engl J Med (1989) 1.51

Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ (1989) 1.48

Spontaneous noncardiac chest pain. Evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Gastroenterology (1988) 1.38

Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36

Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology (1984) 1.36

Liver transplantation in the management of fulminant hepatic failure. Gastroenterology (1989) 1.35

Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion (1988) 1.34

Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res (1988) 1.33

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci (1988) 1.25

Water, electrolyte, glucose, and glycine absorption in rat small intestinal transplants. Gastroenterology (1988) 1.24

Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology (1989) 1.21

Family occurrence of achalasia and diffuse spasm of the oesophagus. Gut (1988) 1.21

Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer (1988) 1.15

Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol (1989) 1.14

Oral phenytoin pharmacokinetics during omeprazole therapy. Br J Clin Pharmacol (1987) 1.13

Controlled trial of heater probe treatment in bleeding peptic ulcers. Br J Surg (1989) 1.09

Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms. Gastroenterology (1989) 1.07

Choice of therapy for achalasia in relation to age. Digestion (1988) 1.04

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis. Gut (1988) 1.02

Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study. Aliment Pharmacol Ther (1988) 1.02

Regression of Barrett's epithelium with omeprazole. N Engl J Med (1989) 0.97

Consensus conference: Therapeutic endoscopy and bleeding ulcers. JAMA (1989) 0.96

Oral-rehydration therapy--the role of polymeric substrates. N Engl J Med (1988) 0.95

Endoscopic biliary prostheses as treatment for benign postoperative bile duct strictures. Gastrointest Endosc (1989) 0.95

Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus. Gut (1989) 0.95

24 hour ambulatory oesophageal motility monitoring: how should motility data be analysed? Gut (1989) 0.94

A study of octreotide in oesophageal varices. Digestion (1990) 0.93

Effect of calcium supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut (1989) 0.93

Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology (1990) 0.93

Quantitative assessment of the response to therapy in achalasia of the cardia. Gut (1989) 0.93

Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass. Gut (1989) 0.92

Psychiatric screening for patients with faecal incontinence or chronic constipation referred for surgical treatment. Br J Surg (1989) 0.92

Sonography in patients with suspected acute appendicitis: value in establishing alternative diagnoses. AJR Am J Roentgenol (1989) 0.91

A clinical evaluation of ultrasonography in the diagnosis of acute appendicitis. Surgery (1989) 0.90

Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology (1989) 0.90

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study. Gut (1989) 0.89

Stress and oesophageal motility in normal subjects and patients with irritable bowel syndrome. Gut (1989) 0.87

Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology (1989) 0.87

Detection of esophageal motor disorders by radionuclide transit studies. A reappraisal. Dig Dis Sci (1989) 0.87

Loss of absorptive capacity for sodium chloride as a cause of diarrhea following partial ileal and right colon resection. Dig Dis Sci (1989) 0.86

Hepatic encephalopathy. Med Clin North Am (1989) 0.83

Current status of intestinal transplantation. Gut (1989) 0.83

Clearance of spontaneous gastroesophageal reflux in awake and sleeping infants. Gastroenterology (1989) 0.83

Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy. Gastroenterology (1989) 0.81

NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances. Ann Intern Med (1989) 0.80

Technetium pertechnetate esophageal imaging for detection of Barrett's esophagus. Dig Dis Sci (1989) 0.79

Sodium-proton exchange in human ileal brush-border membrane vesicles. Biochim Biophys Acta (1989) 0.79

Induction of and adaptation to olsalazine induced intestinal volume load. Scand J Gastroenterol Suppl (1988) 0.78

Small bowel transplantation in the rat. Effect of pretransplant blood transfusions and cyclosporine on host survival. Transplantation (1988) 0.78

Ultrasonography shows no abnormality of pelvic structures in women with severe idiopathic constipation. Gut (1989) 0.78

Malignant jaundice: results of diagnostic and therapeutic endoscopy. World J Surg (1989) 0.77

Interferon therapy for chronic type B hepatitis: the promise comes of age. Gastroenterology (1989) 0.76

Phenamil inhibits electrogenic sodium absorption in rabbit ileum. Gastroenterology (1989) 0.76

Management of biliary obstruction. A comparison of percutaneous, endoscopic, and operative techniques. Arch Surg (1989) 0.76

Liver transplantation. Med Clin North Am (1989) 0.75

Articles by these authors

Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea. Lancet (1994) 4.23

Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut (1991) 2.64

Jejunal efflux in short bowel syndrome. Lancet (1990) 2.52

Diagnosis of giardiasis by specific IgM antibody enzyme-linked immunosorbent assay. Lancet (1986) 2.04

Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut (1978) 1.87

Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology (1997) 1.86

Crucial role for 5-HT in cholera toxin but not Escherichia coli heat-labile enterotoxin-intestinal secretion in rats. Gastroenterology (1998) 1.85

Inflammation in ileal reservoirs: 'pouchitis'. Gut (1990) 1.80

Dilutional diarrhoea: under-diagnosed and over-investigated. Eur J Gastroenterol Hepatol (2000) 1.75

Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies. Gut (1988) 1.70

Intestinal transit in anxiety and depression. Gut (1996) 1.67

Research misconduct. Gut (1997) 1.67

One-minute endoscopy room test for Campylobacter pylori. Lancet (1988) 1.64

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut (1998) 1.62

Travellers' diarrhoea. BMJ (1993) 1.57

Retractions in Gut 10 years after publication. Gut (2001) 1.49

Diagnostic and therapeutic efficacy of barium meal examination: a prospective evaluation in general practice. BMJ (1989) 1.46

The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology (2000) 1.43

Irritable bowel syndrome. QJM (1995) 1.40

A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res (1998) 1.36

Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology (1990) 1.35

The use of rats associated with a human faecal flora as a model for studying the effects of diet on the human gut microflora. J Appl Bacteriol (1987) 1.35

Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut (1994) 1.34

Mammalian bile promotes growth of Giardia lamblia in axenic culture. Trans R Soc Trop Med Hyg (1983) 1.33

K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology (1997) 1.29

Cimetidine in the prevention of gastric ulcer relapse. Postgrad Med J (1979) 1.29

Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut (1993) 1.28

Description and characterization of a surface lectin from Giardia lamblia. Infect Immun (1986) 1.28

Water and solute absorption from a new hypotonic oral rehydration solution: evaluation in human and animal perfusion models. Gut (1992) 1.26

Water, electrolyte, glucose, and glycine absorption in rat small intestinal transplants. Gastroenterology (1988) 1.24

Natural history of Giardia infection of infants and children in rural Guatemala and its impact on physical growth. Am J Clin Nutr (1986) 1.20

Promotion of gallbladder emptying by intravenous aminoacids. Lancet (1993) 1.19

Attachment of Giardia lamblia to rat intestinal epithelial cells. Gut (1988) 1.18

Efficacy of oral rehydration solutions in a rat model of secretory diarrhea. J Pediatr Gastroenterol Nutr (1988) 1.17

Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut (1992) 1.16

Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology (2001) 1.16

Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol (1998) 1.15

5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut (1994) 1.15

The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut (1998) 1.13

Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut (2000) 1.13

Characterization of Helicobacter pylori PldA, a phospholipase with a role in colonization of the gastric mucosa. Gastroenterology (1999) 1.12

Attachment of Giardia lamblia trophozoites to a cultured human intestinal cell line. Gut (1995) 1.11

Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther (1994) 1.11

Functional analysis of the roles of FliQ and FlhB in flagellar expression in Helicobacter pylori. FEMS Microbiol Lett (1999) 1.10

Screening for asymptomatic colorectal cancer. BMJ (1997) 1.10

Effects of bile and bile salts on growth and membrane lipid uptake by Giardia lamblia. Possible implications for pathogenesis of intestinal disease. J Clin Invest (1985) 1.10

Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol (2001) 1.10

Effect of bicarbonate, acetate, and citrate on water and sodium movement in normal and cholera toxin-treated rat small intestine. Scand J Gastroenterol (1989) 1.09

Giardia lamblia: evaluation of roller bottle cultivation. Exp Parasitol (1982) 1.07

Reappraisal of the 'lectin hypothesis' in the aetiopathogenesis of coeliac disease. Clin Sci (Lond) (1986) 1.06

Ambulatory small intestinal motility in 'diarrhoea' predominant irritable bowel syndrome. Gut (1994) 1.05

Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut (1995) 1.05

Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther (1990) 1.05

Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. Gut (1981) 1.05

Delayed puberty and response to testosterone in a rat model of colitis. Am J Physiol Regul Integr Comp Physiol (2001) 1.04

Mycobacterium paratuberculosis and Crohn's disease. Gut (1991) 1.03

Male gonadal function in coeliac disease: 2. Sex hormones. Gut (1983) 1.02

Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines. Br J Cancer (1999) 1.02

5-hydroxytryptamine release into human jejunum by cholera toxin. Gut (1996) 1.01

Field evaluation of a rapid, simple and inexpensive urease test for the detection of Helicobacter pylori. J Gastroenterol Hepatol (1993) 1.00

L-Arginine, nitric oxide, and intestinal secretion: studies in rat jejunum in vivo. Gut (1996) 1.00

Acetate and citrate stimulate water and sodium absorption in the human jejunum. Digestion (1986) 0.99

The prevalence and aetiology of persistent diarrhoea in adults in urban Zambia. Acta Trop (1996) 0.99

Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut (1993) 0.98

Cancer and mutant DNA in blood plasma. Lancet (1996) 0.98

Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and tryptophan in plasma and urine by HPLC with fluorimetric detection. Biomed Chromatogr (1995) 0.98

Selective COX-2 inhibitors and human inflammatory bowel disease. Aliment Pharmacol Ther (1999) 0.97

The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat. Br J Pharmacol (2000) 0.97

In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: a segmental perfusion study. Aliment Pharmacol Ther (1997) 0.97

A double-blind randomized trial of low-dose versus high-dose topical anaesthesia in unsedated upper gastrointestinal endoscopy. Aliment Pharmacol Ther (1996) 0.96

Factors associated with tolerance to, and discomfort with, unsedated diagnostic gastroscopy. Scand J Gastroenterol (2001) 0.96

Histopathological changes in the liver after allogeneic bone marrow transplantation. J Clin Pathol (1980) 0.96

Helicobacter pylori pore-forming cytolysin orthologue TlyA possesses in vitro hemolytic activity and has a role in colonization of the gastric mucosa. Infect Immun (2001) 0.96

Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Gut (1997) 0.95

The use of 3,3',5,5'-tetramethylbenzidine as a peroxidase substrate in microplate enzyme-linked immunosorbent assay. J Immunoassay (1987) 0.95

Bowel function and transit rate during the menstrual cycle. Gut (1989) 0.95

Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases. Gut (1989) 0.95

Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther (1989) 0.95

The E-cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation. J Pathol (1999) 0.95

Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci (2001) 0.95

Water and solute absorption from hypotonic glucose-electrolyte solutions in human jejunum. Gut (1992) 0.95

Nature of the toxicity of cyclosporin A in the rat. Biochem Pharmacol (1981) 0.95

Nutrition and infection. Annu Rev Nutr (1986) 0.94

Parasitic infection of the gut and protein-losing enteropathy. J Pediatr Gastroenterol Nutr (1992) 0.94

Indomethacin and postprandial gallbladder emptying. Lancet (1992) 0.94

Changing patterns of sedation use for routine out-patient diagnostic gastroscopy between 1989 and 1998. Aliment Pharmacol Ther (2001) 0.94

An 88,000-Mr Giardia lamblia surface protein which is immunogenic in humans. Infect Immun (1986) 0.94

Effect of granisetron on cholera toxin-induced enteric secretion. Lancet (1997) 0.94

Giardia-bile salt interactions in vitro and in vivo. Trans R Soc Trop Med Hyg (1988) 0.94

Male gonadal function in coeliac disease: 1. Sexual dysfunction, infertility, and semen quality. Gut (1982) 0.93

A prospective controlled trial of an ultrathin versus a conventional endoscope in unsedated upper gastrointestinal endoscopy. Endoscopy (2001) 0.93

Open access endoscopy ... or barium meal? Br Med J (Clin Res Ed) (1985) 0.93

Neurokinin 1 and 2 receptors mediate cholera toxin secretion in rat jejunum. Gastroenterology (2000) 0.93

The role of bicarbonate and base precursors in treatment of acute gastroenteritis. Arch Dis Child (1987) 0.92

Lactobacilli to prevent traveler's diarrhea? N Engl J Med (1995) 0.92

Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology (2000) 0.91

Effect of bicarbonate on efficacy of oral rehydration therapy: studies in an experimental model of secretory diarrhoea. Gut (1988) 0.91

Diagnosis of Strongyloides and hookworm infections: comparison of faecal and duodenal fluid microscopy. Trans R Soc Trop Med Hyg (1991) 0.91

Dominant role for osmolality in the efficacy of glucose and glycine-containing oral rehydration solutions: studies in a rat model of secretory diarrhoea. Acta Paediatr (1992) 0.91